美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
JUVISYNC	202343	001	NDA	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	10MG;EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2011/10/07	2011/10/07	MERCK SHARP DOHME	Discontinued
JUVISYNC	202343	002	NDA	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	20MG;EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2011/10/07	2011/10/07	MERCK SHARP DOHME	Discontinued
JUVISYNC	202343	003	NDA	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	40MG;EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2011/10/07	2011/10/07	MERCK SHARP DOHME	Discontinued
JUVISYNC	202343	004	NDA	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	10MG;EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2011/10/07	2012/09/18	MERCK SHARP DOHME	Discontinued
JUVISYNC	202343	005	NDA	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	20MG;EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2011/10/07	2012/09/18	MERCK SHARP DOHME	Discontinued
JUVISYNC	202343	006	NDA	SIMVASTATIN; SITAGLIPTIN PHOSPHATE	TABLET;ORAL	40MG;EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2011/10/07	2012/09/18	MERCK SHARP DOHME	Discontinued